Evaluation of hs-CRP in Type 2 Diabetes Mellitus and its Relationship with Glycemic Control and Disease Complications
DOI:
https://doi.org/10.46966/msjar.v5i2.194Keywords:
hs-CRP, T2DM, Complications, Glycemic ControlAbstract
Background: Type 2 diabetes mellitus is the predominant kind of condition characterized by impaired insulin production. It is linked to a disturbance in the metabolism of lipids, proteins, and carbohydrates. Aim of the study: The present study try to explore the role of inflammation process in type 2 diabetes mellitus (T2DM) through assessment the level of High Sensitivity-CRP (hs- CRP). Subject and Methods: The study is a case-control study conclude 78 randomly selected patients with mean age 60.44 ± 11.18 years old and they had a documented medical records of T2DM, they invited to participation in the study when they attended to The Specialist Centre for diseases of Endocrine and Diabetes in Babylon for medical checkup. The healthy control group consists of 57 randomly selected non diabetic volunteers, with mean age 57.37 ± 9.16 years old, all of them had normal fasting blood glucose and normal HbA1c. Both diabetic and healthy control groups were matched in regard to age and sex and other demographic characters while there is difference between them in regard family history for diabetes as well as in RBS & HbA1c. Serum levels of hs-CRP were measured by ELISA technique. Results: The results showed that the mean serum concentrations of hs-CRP were significantly higher in diabetic patients than control, 0.93 ± 0.27 ng/ml in patients versus 0.36 ± 0.18 ng/ml in controls, respectively) with p< 0.001, the mean level of hs-CRP inpatients with poor glycemic control had approximately double the mean level of than those with good glycemic control,, P=0.02. Conclusion: the high levels of hs-CRP among diabetes strength the inflammatory hypothesis that predispose to T2DM.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Ghsin Al-ban Adnan Ouda, Suaad Mohammed H. Rasheed

This work is licensed under a Creative Commons Attribution 4.0 International License.
In submitting the manuscript to the Medical Science Journal for Advance Research, the authors certify that:
- They are authorized by their co-authors to enter into these arrangements.
- The work described has not been formally published before, except in the form of an abstract or as part of a published lecture, review, thesis, or overlay journal.
- That it is not under consideration for publication elsewhere,
- The publication has been approved by the author(s) and by responsible authorities – tacitly or explicitly – of the institutes where the work has been carried out.
- They secure the right to reproduce any material that has already been published or copyrighted elsewhere.
- They agree to the following license and copyright agreement.
License and Copyright Agreement
Authors who publish with Medical Science Journal for Advance Research agree to the following terms:
- Authors retain copyright and grant the Medical Science Journal for Advance Research right of first publication with the work simultaneously licensed under Creative Commons Attribution License (CC BY 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors can enter into separate, additional contractual arrangements for the non-exclusive distribution of the Medical Science Journal for Advance Research published version of the work (e.g., post it to an institutional repository or edit it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) before and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.


















